353 related articles for article (PubMed ID: 8735174)
1. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
2. Evidence of an antiplatelet aggregation action of doxazosin in patients with hypertension: an ex vivo study.
Hernandez Hernandez R; Guerrero Pajuelo JR; Carvajal AR; Armas Padilla MC; Armas de Hernandez MJ; Barragan O; Boada Boada JJ
Am Heart J; 1991 Jan; 121(1 Pt 2):395-401. PubMed ID: 1824666
[TBL] [Abstract][Full Text] [Related]
3. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
Bur A; Woisetschläger C; Herkner H; Derhaschnig U; Quehenberger P; Hirschl MM
Z Kardiol; 2002 Sep; 91(9):685-92. PubMed ID: 12448067
[TBL] [Abstract][Full Text] [Related]
4. The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study.
Hernandez Hernandez R; Carvajal AR; Guerrero Pajuelo J; Armas de Hernandez MJ; Armas Padilla MC; Barragan O; Boada Boada JJ; Roa E
Am Heart J; 1991 Jan; 121(1 Pt 2):389-94. PubMed ID: 1824665
[TBL] [Abstract][Full Text] [Related]
5. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
Ames RP; Kiyasu JY
J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension.
Trost BN; Weidmann P; Riesen W; Claessens J; Streulens Y; Nelemans F
Am J Cardiol; 1987 May; 59(14):99G-104G. PubMed ID: 2884861
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
Silke B; Guy S; Humphreys JE
J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin.
Hayduk K; Schneider HT
Am J Cardiol; 1987 May; 59(14):95G-98G. PubMed ID: 2884860
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group.
Grimm RH; Flack JM; Grandits GA; Elmer PJ; Neaton JD; Cutler JA; Lewis C; McDonald R; Schoenberger J; Stamler J
JAMA; 1996 May 22-29; 275(20):1549-56. PubMed ID: 8622245
[TBL] [Abstract][Full Text] [Related]
11. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
[TBL] [Abstract][Full Text] [Related]
12. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
13. A multicentre, hospital study of the efficacy and safety of terazosin and its effects on the plasma cholesterol levels of patients with essential hypertension.
Lytle TB; Coles SJ; Waite MA
J Clin Pharm Ther; 1991 Aug; 16(4):263-73. PubMed ID: 1682328
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
Abraham PA; Halstenson CE; Matzke GR; Napier JL; Keane WF
Pharmacotherapy; 1985; 5(5):285-9. PubMed ID: 2866492
[TBL] [Abstract][Full Text] [Related]
15. Effect of terazosin on serum lipids.
Deger G
Am J Med; 1986 May; 80(5B):82-5. PubMed ID: 2872813
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with doxazosin in general medical practice.
Rosenthal J
Am Heart J; 1988 Dec; 116(6 Pt 2):1748-57. PubMed ID: 2904745
[TBL] [Abstract][Full Text] [Related]
17. An open one-year comparison of doxazosin and prazosin for mild to moderate essential hypertension.
Torvik D; Madsbu HP
Am J Cardiol; 1987 May; 59(14):68G-72G. PubMed ID: 2884855
[TBL] [Abstract][Full Text] [Related]
18. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
[TBL] [Abstract][Full Text] [Related]
19. Doxazosin in the treatment of mild and moderate essential hypertension in general medical practice.
van den Hogen AL
Am Heart J; 1988 Dec; 116(6 Pt 2):1757-62. PubMed ID: 2904746
[TBL] [Abstract][Full Text] [Related]
20. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S; Monk JP
Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]